XTL BIOPHARMACEUTICALS LTD. Retained Earnings
XTL BIOPHARMACEUTICALS LTD. (XTLB) had Retained Earnings of -$159.01 million as of 2024-12-31, per its 20-F filed 2025-04-30.
Financial Statements › Notes
ifrs-full:RetainedEarnings · last filed 2025-04-30
- 2024-12-31: Retained Earnings -$159.01M.
- 2023-12-31: Retained Earnings -$158.25M.
- 2022-12-31: Retained Earnings -$156.47M.
- 2022-06-30: Retained Earnings -$154.90M.
| Period end | Retained Earnings | Retained Earnings as first filed |
|---|---|---|
| 2024-12-31 | -$159.01M 20-F · filed 2025-04-30 | |
| 2023-12-31 | -$158.25M 20-F · filed 2025-04-30 | |
| 2022-12-31 | -$156.47M 20-F · filed 2023-03-22 | |
| 2022-06-30 | -$154.90M 6-K · filed 2022-08-24 | |
| 2021-12-31 | -$155.13M 20-F · filed 2023-03-22 | |
| 2021-06-30 | -$156.45M 6-K · filed 2021-08-24 | |
| 2020-12-31 | -$155.60M 20-F · filed 2022-03-30 | -$154.66M 20-F · filed 2021-03-15 |
| 2019-12-31 | -$152.70M 20-F/A · filed 2021-05-19 | -$153.93M 20-F · filed 2020-03-12 |
| 2019-01-01 | -$151.94M 20-F/A · filed 2021-05-19 | |
| 2018-12-31 | -$152.59M 20-F · filed 2020-03-12 | |
| 2017-12-31 | -$155.65M 20-F · filed 2019-03-11 | |
| 2016-12-31 | -$154.90M 20-F · filed 2018-03-15 |